title: 1999 WHO/ISH Hypertension Guidelines--highlights & ESH update.
authors.affiliation: Department of Cardiology, Ullevaal University Hospital, Oslo, Norway.
authors.forename: Sverre E
authors.initials: SE
authors.lastname: Kjeldsen
authors.forename: Serap
authors.initials: S
authors.lastname: Erdine
authors.forename: Csaba
authors.initials: C
authors.lastname: Farsang
authors.forename: Peter
authors.initials: P
authors.lastname: Sleight
authors.forename: Guiseppe
authors.initials: G
authors.lastname: Mancia
mesh_terms: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D018660:Blood Pressure Monitoring, Ambulatory / Q000592:standards; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy; D005060:Europe; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D010506:Periodicals as Topic; D011945:Receptors, Angiotensin / Q000627:therapeutic use; D012955:Societies, Medical / Q000592:standards; D014944:World Health Organization
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D011945:Receptors, Angiotensin